PROVEN PRODUCTS
DRIVING
HEALTHY
GROWTH

Proven products are vital to Z-Medica’s success.

Our growing product portfolio offers effective solutions that help customers save money and time, making QuikClot® a product of choice across several markets.


QUIKCLOT® KAOLIN TECHNOLOGY ACCELERATES THE BODY'S NATURAL CLOTTING CASCADE 1,2

For more than 8 years, QuikClot® hemostatic devices have been made with kaolin. Kaolin works on contact with blood to immediately initiate the clotting process by activating factor XII.2

This reaction leads to the transformation of factor XII to its activated form XIIa, which instigates the rest of the coagulation cascade.3

PATENTED TECHNOLOGY 

Z-Medica diligently protects its innovations and has strategically developed several families of strong patents covering its products. We believe it is also critical to protect the company’s inventions by continuously expanding our patent portfolio.

NUMBER OF PATENTS
Region Issued Pending
US 23 5
International 82 29

Z-Medica has been awarded numerous patents in the US and other jurisdictions around the world. Each of Z-Medica’s commercialized hemostatic medical devices is covered by patents in the US and other jurisdictions. Our patent portfolio is a valuable business asset.

 

  1. Trabattoni D, Montorsi P, Fabbiocchi F, Lualdi A, Gatto P, Bartorelli A. A new kaolin-based haemostatic bandage compared with manual compression for bleeding control after percutaneous coronary procedures. Eur Radiol. 2011;21:1687-1691.
  2. Lamb KM, Pitcher HT, Cavarocchi NC, Hirose H. Vascular site hemostasis in percutaneous extracorporeal membrane oxygenation therapy. Open Cardiovasc Thorac Surg J. 2012;5:8-10.
  3. Dee KC, Puleo DA, Bizios R. Tissue-Biomaterial Interactions. Hoboken: Wiley & Sons, 2002.

Leaving Z-Medica.com

Our site includes links to third party sites in which the Z-Medica® Privacy Policy and Terms of Use do not apply. Please read the privacy policy for every third party website you visit.

Close Continue Close